437 related articles for article (PubMed ID: 16869850)
1. Tobacco industry sponsorship of a book and conflict of interest.
Hong MK; Bero LA
Addiction; 2006 Aug; 101(8):1202-11. PubMed ID: 16869850
[TBL] [Abstract][Full Text] [Related]
2. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
3. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
Babor TF
Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
[TBL] [Abstract][Full Text] [Related]
4. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
Muggli ME; Hurt RD; Becker LB
Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
[TBL] [Abstract][Full Text] [Related]
5. 'It's interesting how few people die from smoking': tobacco industry efforts to minimize risk and discredit health promotion.
Smith EA
Eur J Public Health; 2007 Apr; 17(2):162-70. PubMed ID: 16837518
[TBL] [Abstract][Full Text] [Related]
6. Publication ethics and the ghost management of medical publication.
Sismondo S; Doucet M
Bioethics; 2010 Jul; 24(6):273-83. PubMed ID: 19222451
[TBL] [Abstract][Full Text] [Related]
7. Research from tobacco industry affiliated authors: need for particular vigilance.
Chapman S
Tob Control; 2005 Aug; 14(4):217-9. PubMed ID: 16046673
[No Abstract] [Full Text] [Related]
8. The development of scientific consultants: how the tobacco industry creates controversy on the carcinogenicity of tobacco-specific nitrosamines.
Kyriss T; Schneider NK
Tob Control; 2013 May; 22(3):e3. PubMed ID: 22940678
[TBL] [Abstract][Full Text] [Related]
9. Haunted manuscripts: ghost authorship in the medical literature.
Ngai S; Gold JL; Gill SS; Rochon PA
Account Res; 2005; 12(2):103-14. PubMed ID: 16220624
[TBL] [Abstract][Full Text] [Related]
10. Funding food science and nutrition research: financial conflicts and scientific integrity.
Rowe S; Alexander N; Clydesdale F; Applebaum R; Atkinson S; Black R; Dwyer J; Hentges E; Higley N; Lefevre M; Lupton J; Miller S; Tancredi D; Weaver C; Woteki C; Wedral E;
Nutr Rev; 2009 May; 67(5):264-72. PubMed ID: 19386030
[TBL] [Abstract][Full Text] [Related]
11. [The cynical game of the tobacco industry. Many years' efforts to deny or cover-up the negative effects of tobacco are revealed by the forced publication of internal documents].
Lambe M; Hallhagen E; Boëthius G
Lakartidningen; 2002 Jun; 99(24):2756-62. PubMed ID: 12101604
[TBL] [Abstract][Full Text] [Related]
12. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
Bitton A; Neuman MD; Barnoya J; Glantz SA
Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
[TBL] [Abstract][Full Text] [Related]
13. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease.
Tong EK; Glantz SA
Circulation; 2007 Oct; 116(16):1845-54. PubMed ID: 17938301
[TBL] [Abstract][Full Text] [Related]
14. The impact of strategic funding by the tobacco industry of medical expert witnesses appearing for the defence in the Aho Finnish product liability case.
Hiilamo HT
Addiction; 2007 Jun; 102(6):979-88. PubMed ID: 17523993
[TBL] [Abstract][Full Text] [Related]
15. Industry-sponsored research.
Okike K; Kocher MS; Mehlman CT; Bhandari M
Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
[TBL] [Abstract][Full Text] [Related]
16. Nicotine analogues: a review of tobacco industry research interests.
Vagg R; Chapman S
Addiction; 2005 May; 100(5):701-12. PubMed ID: 15847628
[TBL] [Abstract][Full Text] [Related]
17. Industry sponsorship and authorship of clinical trials over 20 years.
Buchkowsky SS; Jewesson PJ
Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
[TBL] [Abstract][Full Text] [Related]
18. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research.
Barnes DE; Bero LA
J Health Polit Policy Law; 1996; 21(3):515-42. PubMed ID: 8784687
[TBL] [Abstract][Full Text] [Related]
19. The limits of competing interest disclosures.
Bero LA; Glantz S; Hong MK
Tob Control; 2005 Apr; 14(2):118-26. PubMed ID: 15791022
[TBL] [Abstract][Full Text] [Related]
20. The Philip Morris External Research Program: results from the first round of projects.
Hirschhorn N; Bialous SA; Shatenstein S
Tob Control; 2006 Jun; 15(3):267-9. PubMed ID: 16728760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
